Cargando…

The apolipoprotein receptor LRP3 compromises APP levels

BACKGROUND: Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis and in transducing signals, but also in amyloid precursor protein (APP) processing and β-amyloid secretion. ApoER2/LRP8 is a member of this family with key roles in synaptic plasticity in the adult b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuchillo-Ibañez, Inmaculada, Lennol, Matthew P., Escamilla, Sergio, Mata-Balaguer, Trinidad, Valverde-Vozmediano, Lucía, Lopez-Font, Inmaculada, Ferrer, Isidro, Sáez-Valero, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565065/
https://www.ncbi.nlm.nih.gov/pubmed/34727970
http://dx.doi.org/10.1186/s13195-021-00921-5
_version_ 1784593742207909888
author Cuchillo-Ibañez, Inmaculada
Lennol, Matthew P.
Escamilla, Sergio
Mata-Balaguer, Trinidad
Valverde-Vozmediano, Lucía
Lopez-Font, Inmaculada
Ferrer, Isidro
Sáez-Valero, Javier
author_facet Cuchillo-Ibañez, Inmaculada
Lennol, Matthew P.
Escamilla, Sergio
Mata-Balaguer, Trinidad
Valverde-Vozmediano, Lucía
Lopez-Font, Inmaculada
Ferrer, Isidro
Sáez-Valero, Javier
author_sort Cuchillo-Ibañez, Inmaculada
collection PubMed
description BACKGROUND: Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis and in transducing signals, but also in amyloid precursor protein (APP) processing and β-amyloid secretion. ApoER2/LRP8 is a member of this family with key roles in synaptic plasticity in the adult brain. ApoER2 is cleaved after the binding of its ligand, the reelin protein, generating an intracellular domain (ApoER2-ICD) that modulates reelin gene transcription itself. We have analyzed whether ApoER2-ICD is able to regulate the expression of other LDL receptors, and we focused on LRP3, the most unknown member of this family. We analyzed LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer’s disease (AD)-related pathology, and the relation of LRP3 with APP. METHODS: The effects of full-length ApoER2 and ApoER2-ICD overexpression on protein levels, in the presence of recombinant reelin or Aβ42 peptide, were evaluated by microarray, qRT-PCRs, and western blots in SH-SY5Y cells. LRP3 expression was analyzed in human frontal cortex extracts from MA subjects (mean age 51.8±4.8 years) and AD-related pathology subjects [Braak neurofibrillary tangle stages I–II, 68.4±8.8 years; III–IV, 80.4 ± 8.8 years; V–VI, 76.5±9.7 years] by qRT-PCRs and western blot; LRP3 interaction with other proteins was assessed by immunoprecipitation. In CHO cells overexpressing LRP3, protein levels of full-length APP and fragments were evaluated by western blots. Chloroquine was employed to block the lysosomal/autophagy function. RESULTS: We have identified that ApoER2 overexpression increases LRP3 expression, also after reelin stimulation of ApoER2 signaling. The same occurred following ApoER2-ICD overexpression. In extracts from subjects with AD-related pathology, the levels of LRP3 mRNA and protein were lower than those in MA subjects. Interestingly, LRP3 transfection in CHO-PS70 cells induced a decrease of full-length APP levels and APP-CTF, particularly in the membrane fraction. In cell supernatants, levels of APP fragments from the amyloidogenic (sAPPα) or non-amyloidogenic (sAPPβ) pathways, as well as Aβ peptides, were drastically reduced with respect to mock-transfected cells. The inhibitor of lysosomal/autophagy function, chloroquine, significantly increased full-length APP, APP-CTF, and sAPPα levels. CONCLUSIONS: ApoER2/reelin signaling regulates LRP3 expression, whose levels are affected in AD; LRP3 is involved in the regulation of APP levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-021-00921-5.
format Online
Article
Text
id pubmed-8565065
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85650652021-11-04 The apolipoprotein receptor LRP3 compromises APP levels Cuchillo-Ibañez, Inmaculada Lennol, Matthew P. Escamilla, Sergio Mata-Balaguer, Trinidad Valverde-Vozmediano, Lucía Lopez-Font, Inmaculada Ferrer, Isidro Sáez-Valero, Javier Alzheimers Res Ther Research BACKGROUND: Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis and in transducing signals, but also in amyloid precursor protein (APP) processing and β-amyloid secretion. ApoER2/LRP8 is a member of this family with key roles in synaptic plasticity in the adult brain. ApoER2 is cleaved after the binding of its ligand, the reelin protein, generating an intracellular domain (ApoER2-ICD) that modulates reelin gene transcription itself. We have analyzed whether ApoER2-ICD is able to regulate the expression of other LDL receptors, and we focused on LRP3, the most unknown member of this family. We analyzed LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer’s disease (AD)-related pathology, and the relation of LRP3 with APP. METHODS: The effects of full-length ApoER2 and ApoER2-ICD overexpression on protein levels, in the presence of recombinant reelin or Aβ42 peptide, were evaluated by microarray, qRT-PCRs, and western blots in SH-SY5Y cells. LRP3 expression was analyzed in human frontal cortex extracts from MA subjects (mean age 51.8±4.8 years) and AD-related pathology subjects [Braak neurofibrillary tangle stages I–II, 68.4±8.8 years; III–IV, 80.4 ± 8.8 years; V–VI, 76.5±9.7 years] by qRT-PCRs and western blot; LRP3 interaction with other proteins was assessed by immunoprecipitation. In CHO cells overexpressing LRP3, protein levels of full-length APP and fragments were evaluated by western blots. Chloroquine was employed to block the lysosomal/autophagy function. RESULTS: We have identified that ApoER2 overexpression increases LRP3 expression, also after reelin stimulation of ApoER2 signaling. The same occurred following ApoER2-ICD overexpression. In extracts from subjects with AD-related pathology, the levels of LRP3 mRNA and protein were lower than those in MA subjects. Interestingly, LRP3 transfection in CHO-PS70 cells induced a decrease of full-length APP levels and APP-CTF, particularly in the membrane fraction. In cell supernatants, levels of APP fragments from the amyloidogenic (sAPPα) or non-amyloidogenic (sAPPβ) pathways, as well as Aβ peptides, were drastically reduced with respect to mock-transfected cells. The inhibitor of lysosomal/autophagy function, chloroquine, significantly increased full-length APP, APP-CTF, and sAPPα levels. CONCLUSIONS: ApoER2/reelin signaling regulates LRP3 expression, whose levels are affected in AD; LRP3 is involved in the regulation of APP levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-021-00921-5. BioMed Central 2021-11-02 /pmc/articles/PMC8565065/ /pubmed/34727970 http://dx.doi.org/10.1186/s13195-021-00921-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cuchillo-Ibañez, Inmaculada
Lennol, Matthew P.
Escamilla, Sergio
Mata-Balaguer, Trinidad
Valverde-Vozmediano, Lucía
Lopez-Font, Inmaculada
Ferrer, Isidro
Sáez-Valero, Javier
The apolipoprotein receptor LRP3 compromises APP levels
title The apolipoprotein receptor LRP3 compromises APP levels
title_full The apolipoprotein receptor LRP3 compromises APP levels
title_fullStr The apolipoprotein receptor LRP3 compromises APP levels
title_full_unstemmed The apolipoprotein receptor LRP3 compromises APP levels
title_short The apolipoprotein receptor LRP3 compromises APP levels
title_sort apolipoprotein receptor lrp3 compromises app levels
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565065/
https://www.ncbi.nlm.nih.gov/pubmed/34727970
http://dx.doi.org/10.1186/s13195-021-00921-5
work_keys_str_mv AT cuchilloibanezinmaculada theapolipoproteinreceptorlrp3compromisesapplevels
AT lennolmatthewp theapolipoproteinreceptorlrp3compromisesapplevels
AT escamillasergio theapolipoproteinreceptorlrp3compromisesapplevels
AT matabalaguertrinidad theapolipoproteinreceptorlrp3compromisesapplevels
AT valverdevozmedianolucia theapolipoproteinreceptorlrp3compromisesapplevels
AT lopezfontinmaculada theapolipoproteinreceptorlrp3compromisesapplevels
AT ferrerisidro theapolipoproteinreceptorlrp3compromisesapplevels
AT saezvalerojavier theapolipoproteinreceptorlrp3compromisesapplevels
AT cuchilloibanezinmaculada apolipoproteinreceptorlrp3compromisesapplevels
AT lennolmatthewp apolipoproteinreceptorlrp3compromisesapplevels
AT escamillasergio apolipoproteinreceptorlrp3compromisesapplevels
AT matabalaguertrinidad apolipoproteinreceptorlrp3compromisesapplevels
AT valverdevozmedianolucia apolipoproteinreceptorlrp3compromisesapplevels
AT lopezfontinmaculada apolipoproteinreceptorlrp3compromisesapplevels
AT ferrerisidro apolipoproteinreceptorlrp3compromisesapplevels
AT saezvalerojavier apolipoproteinreceptorlrp3compromisesapplevels